USPTO 2015–2025 USPTO PatentsView US Corporation

RO Technologies, LLC

USPTO PatentsView assignee record - 12 granted patents across 13 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B32B (Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form).

RSS updates for this company

The verdict

According to USPTO PatentsView, RO ranks #23,303 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 13 technology areas.

#23,303
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.6/100)
18.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23303 · US Corporation #23,303 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,303/49,997
  • PHOTO-FINISH Rexahn Pharmaceuticals
  • CPC-FOCUS B32B · 13 areas
  • INNOV-PAR 52.6/100
  • CLAIMS-RICH 18.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2024–2025 · 2y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Rexahn Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How RO’s 52.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around RO

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows RO's Innovation Score is 52.6/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for RO?

Each dot is one of RO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). RO’s own 18.3 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

RO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 0510152025 Granted patents (volume) Avg claims / patent Rexahn Pharmaceuticals, Inc. - 12, 19.17Rexahn Pharmaceut…Rhodia Acetow GMBH - 12, 17.25Rhodia AcetowRiiid Inc. - 12, 8.08RiiidRing-co., LLC - 12, 1Ring-Robertson Fuel Systems, L.L.C. - 12, 17Robertson Fuel Sy…Robin Radar Facilities BV - 12, 13.67Robin Radar Facil…Robocath - 12, 18.75RobocathRoca Medical Ltd. - 12, 9.42Roca MedicalRO Technologies, LLC - 12, 18.25RO
RO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where RO's grants concentrate

RO Technologies, LLC is a focused PatentsView assignee: 13 CPC subclasses with 75% of grants classified under B32B (Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form). By volume, RO sits between Rexahn Pharmaceuticals, Inc. and Roca Medical Ltd..

RO's three-year grant acceleration

RO Technologies, LLC shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at RO's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows RO holds 12 patents at rank #23,274, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near RO

By rank, the assignees closest to #23,274 in granted patent volume.

Leaders in B32B (Layered Products)

Other assignees with the most granted patents in RO's primary technology class.

RO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

3456789 20242025 4
USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table
RO Technologies, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2024 8 66.7%
2025partial year 4 33.3%

Which technologies does RO Technologies, LLC patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

RO Technologies, LLC's patent record in context - here's where to go next.

  • RO Technologies, LLC's lead technology class is B32B (Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form), 75% of its portfolio - see every assignee active in that class. Explore B32B
  • Ranked #23,303 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare RO Technologies, LLC against Rexahn Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.